U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07162454) titled 'Effectiveness of CBD for Neuropathic Pain in Diabetic Foot Neuropathy' on Sept. 01.
Brief Summary: Evaluation of cannabidiol and urea 10%.
Study Start Date: Nov. 01, 2024
Study Type: INTERVENTIONAL
Condition:
Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Xerosis Cutis
Intervention:
DRUG: Group 1. Complete formula
After fulfilling the criteria and agreeing to participate in the study, patients who were included in group 1 after randomisation were evaluated and received a topical cream with cannabidiol, Urea 10%, arnica and menthol as active ingredients. After one month of application of the formula, a second...